Healthcare provider profile · identity verified

Timothy Michael Baumgarte

Nurse Practitioner · REDMOND, OR · NPI 1114584331

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	461	136
Lisinopril	Lisinopril	252	72
Levothyroxine Sodium	Levothyroxine Sodium	208	60
Amlodipine Besylate	Amlodipine Besylate	186	62
Hydrochlorothiazide	Hydrochlorothiazide	170	57
Losartan Potassium	Losartan Potassium	150	48
Omeprazole	Omeprazole	150	49
Metformin Hcl	Metformin Hcl	149	45
Trazodone Hcl	Trazodone Hcl	145	43
Albuterol Sulfate Hfa	Albuterol Sulfate	134	46
Tamsulosin Hcl	Tamsulosin Hcl	131	46
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	118	30
Metoprolol Succinate	Metoprolol Succinate	118	35
Gabapentin	Gabapentin	117	40
Pantoprazole Sodium	Pantoprazole Sodium	101	31
Rosuvastatin Calcium	Rosuvastatin Calcium	97	34
Metformin Hcl Er	Metformin Hcl	96	28
Ozempic	Semaglutide	95	19
Tramadol Hcl	Tramadol Hcl	80	23
Simvastatin	Simvastatin	78	19
Furosemide	Furosemide	73	27
Atenolol	Atenolol	69	21
Sertraline Hcl	Sertraline Hcl	66	21
Allopurinol	Allopurinol	63	16
Eliquis	Apixaban	58	20
Fluoxetine Hcl	Fluoxetine Hcl	55	15
Jardiance	Empagliflozin	55	18
Methocarbamol	Methocarbamol	54	24
Montelukast Sodium	Montelukast Sodium	53	14
Citalopram Hbr	Citalopram Hydrobromide	52	14
Escitalopram Oxalate	Escitalopram Oxalate	48	16
Potassium Chloride	Potassium Chloride	48	17
Pravastatin Sodium	Pravastatin Sodium	47	14
Buspirone Hcl	Buspirone Hcl	46	11
Bupropion Xl	Bupropion Hcl	44	16
Carvedilol	Carvedilol	44	16
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Duloxetine Hcl	Duloxetine Hcl	42	14
Metoprolol Tartrate	Metoprolol Tartrate	42	11
Clopidogrel	Clopidogrel Bisulfate	41	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	13
Oxycodone Hcl	Oxycodone Hcl	40	12
Valsartan	Valsartan	39	13
Fluticasone Propionate	Fluticasone Propionate	38	16
Ondansetron Odt	Ondansetron	38	14
Alendronate Sodium	Alendronate Sodium	37	11
Chlorthalidone	Chlorthalidone	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Estradiol	Estradiol	32	11
Famotidine	Famotidine	32	suppressed
Spironolactone	Spironolactone	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Finasteride	Finasteride	29	suppressed
Meloxicam	Meloxicam	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	13
Hydrocortisone	Hydrocortisone	22	suppressed
Sucralfate	Sucralfate	21	suppressed
Cephalexin	Cephalexin	20	17
Glipizide Er	Glipizide	20	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	20	suppressed
Lorazepam	Lorazepam	19	suppressed
Nystatin	Nystatin	19	11
Alprazolam	Alprazolam	18	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	18	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Prednisone	Prednisone	18	16
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Risperidone	Risperidone	17	suppressed
Azithromycin	Azithromycin	16	16
Colchicine	Colchicine	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Scopolamine	Scopolamine	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Efavirenz-Emtric-Tenofov Disop	Efavirenz/Emtricit/Tenofovr Df	13	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Modafinil	Modafinil	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Ropinirole Er	Ropinirole Hcl	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Diazepam	Diazepam	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Temazepam	Temazepam	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error